What happens when a therapy meets every regulatory requirement, but still isn’t covered? In sleep medicine, this is no longer an exception. It is a pattern. Devices can be FDA-cleared, clinically validated and fully coded, yet remain out of reach for patients due to fragmented and inconsistent payer policies.